Ascent Pharma' Generic Paliperidone Receives Approval in the U.S.
Amid a wave of patent litigation over Johnson & Johnson's portfolio of schizophrenia treatments, the company has successfully batted away a copycat challenge from Viatris.
Enforcement Report - Week of March 16, 2022
Health Canada Recalls Marcan Pharmaceutical`s MAR-Paliperidone Extended Release tablets
Inventia Healthcare`s Generic Paliperidone Receives Approval in US
(Reuters) - Alkermes Plc said on Tuesday its long-acting injectable therapy for schizophrenia has helped reduce symptoms and can become an effective option for ensuring patients stay on medication even after being discharged from hospital.
Janssen's Trevicta (previously Paliperidone Janssen) Receives Approval in US
Janssen-Cilag International NV's Invega (paliperidone) Receives Approval in Europe
Sun Pharma’s Generic Paliperidone Receives Approval In US